1. Introduction {#sec1}
===============

In recent years, the genome editing of human iPS cells has become a common technique. However, for genome editing that involves DNA scission via CRISPR/Cas9 or other techniques, the manipulation of hiPS/hES cells is considered difficult due to their tendency to undergo cell death [@bib1]. On the other hand, human iPS cells have been found to have a high level of accurate homology-dependent repair activity, such as the capacity to allow the knock-in of a homology arm ranging between 150 and 200 bp.

We previously analyzed the gene expression of reprogramming-related genes in hiPS [@bib2]. We further analyzed DNA repair-related genes with respect to the genome stability of hiPS. We found that genome surveyor *PARP-1* and double-stranded break (DSB) repair-related genes such as *RAD51* and *BLM* showed elevated expression through reprogramming.

PARP plays a role in the recognition of DNA damage. The PARP protein detects DNA strand breaks and catalyzes the attachment of ADP-ribose units from NAD to itself and to other proteins. The substrates of PARP-1 (the most abundant PARP family member accounting for \> 85% of nuclear PARP activity) can then influence the architecture of chromatin. Many reports suggest the importance of PARP-1 in the maintenance of genome instability in hiPS cells [@bib3]. However, there have been no reports focusing on PARP activity in hiPS cells. PARP-1 is also involved in DSB repair under the condition of the severe stalling of replication forks associated with DSB [@bib4], [@bib5], [@bib6]. Previously, we reported the generation of iPS cells from clonally expanded mesenchymal stromal cells (MSCs) derived from human third molars (wisdom teeth) [@bib2] and found high levels of PARP-1 in all efficiently reprogrammed clonal cell lines compared with progenitor MSCs via global gene expression profiling. These results implied an important role of PARP-1 in iPS cell generation and maintenance. In the present study, we found a change in PARP-1 expression at the gene and protein levels as well as PARP-1 activity in reprogrammed iPS cells compared to their corresponding parental MSCs.

We also found the increased expression of a series of HR-related genes in contrast to NHEJ pathway genes. Yoshimura et al. were the first to isolate *RAD51* from higher animals [@bib7], [@bib8], [@bib9]. Because the absence of *RAD51* is associated with embryonic lethality, it is considered essential for cell proliferation [@bib10]. Cells are thought to become incapable of repairing DNA double-strand breaks (DSBs) associated with excessive oxidative damage occurring during vigorous proliferation, and, thus, they progress to apoptosis. To date, many findings have shown that in mouse ES cells, the frequency of single-strand breaks (SSB) repaired by PARP is high [@bib11] and that the repair capability is reduced after differentiation [@bib12], whereas in human ES cells, the capability of repairing DNA damage remains high [@bib13], [@bib14]. Our findings in the present study showed that PARP activity significantly increased through the reprogramming of progenitor fibroblasts and that the expression of HR-related gene groups also increased through reprogramming. Our findings provide a reasonable mechanistic basis for the accurate transmission of genetic information in hiPS/hES cells.

2. Materials and methods {#sec2}
========================

2.1. Cell culture {#sec2.1}
-----------------

The isolation of human third molars and culture expansion of MSCs (10YP-15) from the molars were carried out from 10-year-old donors after informed consent [@bib15]. The HDFs were purchased from Cell Applications. The HDFs were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; Invitrogen) containing 10% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin. The iPS cells (10YP-15 iPS) were established [@bib2] and cultured in human ES cell medium that consisted of DMEM/F-12 with GlutaMAX-I (Invitrogen) supplemented with 20% knock-out serum replacement (Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), 0.1 mM 2-mercaptoethanol (Invitrogen), 100 units/ml penicillin, 100 μg/ml streptomycin, and 5 ng/ml recombinant human basic fibroblast growth factor (basic FGF; WAKO).

2.2. Microarray analyses {#sec2.2}
------------------------

The microarray data that was used is described in our previous study (accession number [GSE16963](ncbi-geo:GSE16963){#intref0010}) [@bib2]. The analyses were performed according to the Affymetrix technical protocols. Data from these experiments and data from the GEO database were analyzed using the GeneSpring GX10 software and Subio platform software. We extracted the expression scores and compared the 10YP of the MSCs and HDFs to those of the corresponding iPSs (10YP-15 vs. 10YP15 cl1-39, 10YP-15 vs. 10YP15 cl1-58, and HDF vs. HDF iPS1-1, HDF iPS1-8, respectively).

2.3. Real-time PCR gene expression analyses {#sec2.3}
-------------------------------------------

RT-qPCR was performed to confirm the microarray analysis. Total RNA was reverse transcribed to cDNA using the SuperScript III First-Strand Synthesis System for RT-qPCR (Invitrogen, Cat. No. 18080-051). After cDNA preparation, the genes of interest were amplified using TaqMan preamp (Applied Biosystems). Real-time quantitative PCR was performed with an iCycler iQ Multi-Color Real Time PCR Detection System (BIO-RAD) using the following PCR primer sets (Applied Biosystems) and the TaqMan Gene Expression Master Mix: *RAD51*, Hs00179866_m1; *BLM*, Hs00172060_m1; *PARP1*, Hs00242302_m1; *PARP2,* Hs00193931_m1; *PARG*, Hs00608254_m1; *MSH2*, Hs00953523_m1; *MSH6*, Hs00264721_m1; *MLH1*, Hs001534183_m1; and *GAPDH*, Hs99999905_m1. Standard curves were generated for each primer pair. All expression values were normalized to *GAPDH*.

2.4. Western blot analysis {#sec2.4}
--------------------------

Whole cell extracts were used for western blotting. The cells were trypsinized, rinsed, and lysed in lysis buffer (Laemmli sample buffer, Bio-Rad) with a 1/50 dilution of Protease Inhibitor Cocktail intended for Mammalian Cell and Tissue Extraction (Nacalai Tesque, 25955-11) and a 1/100 dilution of Phosphatase Inhibitor Cocktail (Sigma--Aldrich, P2850). Proteins were separated using SDS-PAGE with Ready Gels J 5--15% (Bio-Rad, Cat. No. 161J361V).

All of the antibodies were used at the dilutions shown below in 5% non-fat dry milk in phosphate buffer containing 0.1% Tween-20. After transblotting the proteins, they were incubated with the primary antibodies at 4 °C overnight or at room temperature for 1 h. The following primary antibodies and dilutions were used: PARP-1 rabbit polyclonal (Santa Cruz, sc-25780, 1:200 dilution), PARG goat polyclonal (Santa Cruz, sc-21480, 1:200 dilution), GAPDH mouse monoclonal, (Santa Cruz, sc-47724, 1:800 dilution), and β-Actin (Santa Cruz, sc-47778, 1:800 dilution).

In addition, the following antibodies were also used: BLM rabbit polyclonal (Novus Biologicals, \#NB100-214), RAD51 mouse polyclonal (Abnova, \#H0000588-B01), NBS1 rabbit polyclonal (Novus Biologicals, \#NB100-143), MRE11 rabbit polyclonal (Novus Biologicals, \#NB100-142), RAD50 rabbit polyclonal (Novus Biologicals, \#NB100-154), Ku-80 rabbit polyclonal (Novus Biologicals, \#NB100-92042), and Ku-70 rabbit polyclonal (Novus Biologicals, \#NB100-195). Incubation with the primary antibodies was followed by rinsing and incubation with the secondary antibody for 1 h at room temperature. The secondary antibodies were typically horseradish peroxidase-conjugated sheep anti-mouse or donkey anti-rabbit IgG antibodies (GE Healthcare, 1:1000 dilution). To visualize the proteins, a luminescence detection reagent was prepared immediately before use. The membranes were imaged using the chemiluminescence imager LAS-4000 mini (Fujifilm, Japan). MSH2 mouse monoclonal, (abcam, ab52266, 1:200 dilution), MSH6 mouse polyclonal, (BD Biosciences, 610919, 1:200 dilution), MLH1 (abnova, H00004292-M02, 1:200 dilution).

2.5. PARP assay {#sec2.5}
---------------

The activity of PARP-1 was determined following the procedure of the HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Cat. No. 4677-096-K). Briefly, approximately 2 × 10^6^ iPS cells were centrifuged at 400×*g* for 10 min at 4 °C. The supernatant was discarded and the pellet was suspended in 5--10 pellet volumes of cold 1× PARP buffer containing 0.4 mM PMSF, other protease inhibitors, 0.4 M NaCl, and 1% Triton X-100. The cell suspensions were incubated at 4 °C, with periodic vortexing for 30 min.

The disrupted cell suspensions were centrifuged at 10,000×*g* for 10 min at 4 °C to remove insoluble material. Forty-microliter aliquots of the supernatant were taken, and 10 μl of the poly (ADP-ribose) glycohydrolase (PARG) inhibitor ADP-HPD (Calbiochem, Cat. No. 118415, 60 μg) was added to each aliquot result for a final concentration of 0.2 M ADP-HPD, and the PARP activity was measured. We had examined appropriate concentrations for PARG inhibition in advance, at 0.05, 0.1, 0.2 and 0.25 M, and determined that 0.2 M would be used for the experiment (data not shown). At least 20 μg of protein per well was used in the assay. All samples in 96-well plates were read using a Wallac ARVO SX 1420 Multilabel Counter (PerkinElmer).

3. Results {#sec3}
==========

3.1. High expression levels of PARP-1, PARP-2, and PARG in iPS cells {#sec3.1}
--------------------------------------------------------------------

The array technology, which allowed the simultaneous assessment of all gene sets in the genome, showed increased expression levels of *PARP-1* and several identified poly (ADP ribosylating) enzymes ([Table 1](#tbl1){ref-type="table"}) in the iPS cells; these included *PARP-1* (6.5--12.1 fold), *PARP-2* (2.4--3.0 fold), and *PARG* (2.5--2.6 fold). The microarray results were confirmed by RT-qPCR ([Table 1](#tbl1){ref-type="table"}). The expression of these genes was examined at the protein level as well ([Fig. 1](#fig1){ref-type="fig"}a), and the protein levels of PARP-1 and PARG were found to be upregulated in iPS cells compared to those in the parental cells. PARP-2 could not be detected clearly using several commercially available antibodies. Overall, the expression of PARP-1 and PARG at the gene and protein levels were higher in iPS cells compared to their parental cells. PARP-1 and PARG regulate transcriptional activity by modifying target nuclear proteins via the addition and removal of ADP-ribose polymers, respectively.Table 1Comparative microarray and RT-qPCR analysis in the iPS cell lines and the parental HDF and 10YP cells: HDF clone1 (HDF-1), HDF clone2 (HDF-8), 10YP clone1 (10YP-15 cl1-39), and 10YP clone2 (10YP15 cl1-58). For PARP1, PARP2, PARG, RAD51, BLM, MSH2, MSH6, and MLH1, we include the RT-qPCR data (shown \* line under the microarray data) along with the microarray data.Table 1SymbolAccession No.ProbesetActivityiPS/parental cellHDFThird Molarclone1clone2clone1clone2PARP1[M32721](ncbi-n:M32721){#intref0025}208644_atResponse to DNA damage9.38.212.16.5\* 23.516.217.211.6PARP2[NM_005484](ncbi-n:NM_005484){#intref0030}204752_x\_atResponse to DNA damage2.42.92.83.0\* 2.02.32.22.6PARG[NM_003631](ncbi-n:NM_003631){#intref0035}205060_atpoly (ADP-ribose) glycohydrolase2.52.52.62.5\* 3.43.53.04.1RAD51[NM_002875](ncbi-n:NM_002875){#intref0040}205024_s\_atHR, DNA double-strand break repair7.07.05.16.4\*11.610.710.812.4BLM[NM_000057](ncbi-n:NM_000057){#intref0045}205733_atHR, DNA double-strand break repair15.314.48.48.7\*33.328.626.529.0MSH2[NM_000251.1](ncbi-n:NM_000251.1){#intref0050}209421_atMMR, mismatch repair10.210.45.26.0\*20.315.24.68.5MSH6[NM_000179.2](ncbi-n:NM_000179.2){#intref0055}211450_s\_atMMR, mismatch repair5.74.96.65.2\* 12.39.110.610.1MLH1[NM_000249.2](ncbi-n:NM_000249.2){#intref0060}202520_s\_atMMR, mismatch repair1.81.81.82.0\* 2.82.70.91.2MRE11[NM_005590](ncbi-n:NM_005590){#intref0065}205395_s\_atHR, DNA double-strand break repair2.41.92.12.8RAD50[NM_005732](ncbi-n:NM_005732){#intref0070}208393_s\_atHR, DNA double-strand break repair1.61.12.52.1NBS[NM_002485](ncbi-n:NM_002485){#intref0075}202907_s\_atHR, DNA double-strand break repair1.21.21.31.1XRCC4[NM_003401.3](ncbi-n:NM_003401.3){#intref0080}205071_x\_atNHEJ2.0,1.21.21.5XRCC5 (KU80)[NM_021141.3](ncbi-n:NM_021141.3){#intref0085}208642_s\_atNHEJ2.52.52.72.2XRCC6 (KU70)[NM_001469](ncbi-n:NM_001469){#intref0090}200792_atNHEJ1.82.01.51.3POLH[NM_001291970.1](ncbi-n:NM_001291970.1){#intref0095}231115_attranslesion synthesis0.120.120.020.12REV3L[NM_001286432.1](ncbi-n:NM_001286432.1){#intref0100}238736_attranslesion synthesis0.090.030.030.47Fig. 1High expression levels of PARP-1 and PARG in the iPS cells. (a) PARP-1 and PARG were analyzed via Western blotting. GAPDH was used as a loading control. (b) PARP activity assay. All the samples in the 96-well plates were read on a Wallac ARVO SX 1420 Multilabel Counter (PerkinElmer) using the wavelength settings for optimized fluorescence. The vertical axis represents RFU (relative fluorescence units). The experiments were performed on four biological replicates, for each cell line. Comparison of the two groups (progenitor cells and reprogrammed iPS cells) with normally distributed variables was performed using a Student\'s *t* test analyzed by a Caleida graph. Statistical significance was defined as a value of *p* \< 0.05. Data are expressed as the mean ± SEM.Fig. 1

3.2. High PARP activity in iPS cells {#sec3.2}
------------------------------------

The PARP activity in the iPS cells was approximately 11-fold higher compared to that in the parental HDF cells and approximately 8.5-fold higher compared to that in the 10F15 parental cells ([Fig. 1](#fig1){ref-type="fig"}b). These data are consistent with the mRNA expression data. Compared with PARP activity in somatic cells, PARG catalyzes the hydrolysis of glycosidic bonds of ADP-ribose polymers and produces monomeric ADP-ribose units, while PARP polymerizes monomeric ADP-ribose units. It is thought that the activity of PARG-mediated hydrolysis is stronger than that of PARP-mediated polymerization, and the inhibition of PARG activity is necessary for the measurement of PARP activity [@bib16], [@bib17]. We determined the optimal ADP-HPD concentration by testing different concentrations in PARP activity assays.

3.3. High expression of HR- and MMR-related genes in iPS cells {#sec3.3}
--------------------------------------------------------------

The mRNA and protein levels of HR-related RAD51 and BLM were upregulated in iPS cells compared to those in the parental cells, consistent with the gene expression levels ([Table 1](#tbl1){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}). The levels of NBS1, MRE11, RAD50 and those of NHEJ-related KU70 and KU80 showed a milder upregulation.Fig. 2The protein levels of RAD51 and BLM (HR); NBS1, MRE11, and RAD50 (HR); KU70 and KU80 (NHEJ); MSH2, MSH6, and MLH1 (MMR) were analyzed via Western blotting. β-actin was used as a loading control.Fig. 2

The protein levels of MMR-related MSH2, MSH6 and MLH1 were also upregulated in the iPS cells compared to those in the parental cells, consistent with the gene expression levels ([Table 1](#tbl1){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}).

3.4. Downregulation of error-prone polymerase {#sec3.4}
---------------------------------------------

The expression of error-prone translesion DNA synthesis (TLS) polymerase, such as REV3L and POLH, revealed downregulation through reprogramming ([Table 1](#tbl1){ref-type="table"}).

4. Discussion {#sec4}
=============

Many studies have reported that hiPS/hES cells have an exceptional ability to repair damaged DNA [@bib13], [@bib18], [@bib19]. Most of these reports were based on analyses at the level of gene expression. In the present study, we compared progenitor cells and progenitor-derived hiPS cells and showed that gene expression levels, as well as PARP activity, increased significantly through reprogramming. The elevation of PARP activity is essential to protect against reactive oxygen species (ROS). Although some reports have indicated ROS production during the reprogramming process [@bib20], DNA repair activity is indisputably necessary for iPS cells that show vigorous proliferation after reprogramming, irrespective of whether it occurs in response to ROS. Our study also confirmed that a series of genes involved in HR were also upregulated.

RAD51 and BLM are thought to be necessary for accurate DNA repair after DNA scission. In hiPS cells, upon inhibiting BLM activity using an inhibitor, their proliferation was inhibited by approximately 15% (data not shown). This also suggests that the inhibition of cellular DNA repair results in the loss of cell viability because such cells are no longer able to repair DNA damage.

The expression of MMR-related genes might be an adaptation for the vigorous proliferation of hiPS ([Table 1](#tbl1){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}). Conversely, the expression of error-prone polymerase genes, such as REV3L and POLH, revealed downregulation through reprogramming ([Table 1](#tbl1){ref-type="table"}). Human POLH copies undamaged DNA with much lower fidelity than any other template-dependent DNA polymerase [@bib21], [@bib22]. REV3L is involved in the error-prone translesion synthesis reaction that frequently induces mutations at damaged DNA lesions [@bib23]. It might also be reasonable for the genome stability of stem cells in the replication revel.

Stem cells are inherently capable of highly accurate DNA repair, thereby potentially benefitting genetic manipulation via base substitutions and HR. Compared to mice, hES cells, which are in a slightly more advanced developmental stage, show a tendency to differentiate easily. To improve the efficiency of genome editing, it is important to validate in advance if the cell strain to be used has retained an undifferentiated state. Moreover, in general, hiPS/hES cells often show similarities with cancer stem cells; thus, they have potential applications in cancer treatment. However, it is important to distinguish between hiPS/hES cells that are essentially intolerant to genomic changes and cancer stem cells or their progenitor cells that tolerate such changes and shift to an infinite accumulation of mutations.

During genome editing applications in regenerative medicine, the hiPS/hES cells require prior verification before use to make sure that the entire genome sequence has been retained. In recent years, the possibility of point mutations in iPS cells, occurring not only through reprogramming but also during cell proliferation, has been suggested [@bib24].

Two possibilities have been suggested for the cause of such point mutations observed in the genome of iPS cells. One possibility is that mutations are already present in a parental somatic cell, and they become detectable after exceeding the minimum detection threshold during single cell proliferation, that is, conversion into iPS cells. This hypothesis is based on the idea that the conversion into iPS cells does not cause mutations. The other possibility is that conversion into iPS cells itself causes mutations. In such a case, considering the applications in regenerative medicine, mutations need to be reduced; studying the mechanisms of such mutations may contribute not only to the development of a strategy to reduce mutations but also to the elucidation of the mechanisms of genomic reprogramming. It is highly probable that this is linked to the expression of BER (base excision repair) and HR gene groups; thus, we believe that analysis of the correlation between changes in their expression through reprogramming and genome stability will become even more important in the future.

ES cells are cells in true early development, and they undoubtedly retain their natural function to repair DNA damage. The two types of cells, hiPS and hES cells, are generally considered to have comparable biological characteristics; however, similarities between them in terms of frequency of DNA mutations and ability to repair DNA damage requires further analysis.

5. Conclusions {#sec5}
==============

In genome editing, which relies on DNA cleavage and knock-in mediated by techniques such as CRISPR/Cas9, manipulation of hiPS/hES cells is considered challenging because these cells have a tendency to undergo cell death including apoptosis resulting from the failure of accurate DNA repair via HR. However, because of their high HR-related gene expression, precise genome editing can be carried out relatively easily in them via HR-mediated repair.
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